February 28, 2026
Back to all stories

Rhino Choco VIP 10X Chocolate Recalled for Hidden Erectile‑Dysfunction Drug

Brooklyn-based USALESS.COM is recalling its Rhino Choco VIP 10X male‑enhancement chocolate supplement nationwide after tests found it contains undeclared tadalafil, the prescription‑only active ingredient in Cialis, the company said in an FDA‑posted notice Friday. The recall covers 10‑gram, 12‑piece chocolate supplements in black cardboard boxes bearing an October 2027 expiration date, sold both online and in retail outlets. Because tadalafil can dangerously interact with nitrate medications commonly prescribed for heart disease, diabetes‑related vascular issues, high blood pressure and high cholesterol, the hidden ingredient could drive blood pressure to unsafe levels in unsuspecting users. The company says it has pulled the product from its online store "until we are certain that the problem has been corrected" and is urging customers to stop using the chocolates and return them for a full refund. The FDA previously warned in 2018 that "Rhino"‑branded male‑enhancement products have a history of containing undisclosed drugs, and this case fits that ongoing pattern of tainted sexual‑enhancement supplements masquerading as over‑the‑counter or "natural" remedies.

FDA Recalls and Drug Safety Dietary Supplements and Public Health

📌 Key Facts

  • USALESS.COM is recalling Rhino Choco VIP 10X after finding undeclared tadalafil, the active ingredient in Cialis, in the product.
  • The recall applies to 10‑gram, 12‑piece chocolate supplements in black cardboard boxes with an expiration date of October 2027, sold online and in stores.
  • Tadalafil can interact with nitrate medications and sharply lower blood pressure, posing particular risk to people with diabetes, high blood pressure, high cholesterol or heart disease.

📰 Source Timeline (1)

Follow how coverage of this story developed over time

February 28, 2026
4:58 PM
Chocolate supplement recalled over erectile dysfunction drug
https://www.facebook.com/CBSNews/